Early ischaemic diffusion lesion reduction in patients treated with intravenous tissue plasminogen activator: Infrequent, but significantly associated with recanalization

International Journal of Stroke

Volumn 8, Issue 5, 2013, Pages 321-326

  Sakamoto, Yuki ^a   Kimura, Kazumi ^a   Shibazaki, Kensaku ^a   Inoue, Takeshi ^a   Uemura, Jyunichi ^a   Aoki, Junya ^a   Sakai, Kenichiro ^a   Iguchi, Yasuyuki ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Diffusion weighted imaging; Ischaemic stroke; Lesion volume; Recanalization; Tissue plasminogen activator

Indexed keywords

GLUCOSE; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BRAIN ISCHEMIA; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECANALIZATION;

AGED; AGED, 80 AND OVER; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; ISCHEMIA; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84879495875     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2012.00902.x     Document Type: Article

References (32)

1. Minematsu K, Li L, Fisher M, Sotak CH, Davis MA, Fiandaca MS. Diffusion-weighted magnetic resonance imaging: rapid and quantitative detection of focal brain ischemia. Neurology 1992; 42:235-240.
2. Knight RA, Dereski MO, Helpern JA, Ordidge RJ, Chopp M. Magnetic resonance imaging assessment of evolving focal cerebral ischemia. Comparison with histopathology in rats. Stroke 1994; 25:1252-1261. discussion 1261-1252.
3. Baird AE, Benfield A, Schlaug G etal. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 1997; 41:581-589.
4. Beaulieu C, de Crespigny A, Tong DC, Moseley ME, Albers GW, Marks MP. Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: evolution of lesion volume and correlation with clinical outcome. Ann Neurol 1999; 46:568-578.
5. Karonen JO, Vanninen RL, Liu Y etal. Combined diffusion and perfusion MRI with correlation to single-photon emission CT in acute ischemic stroke. Ischemic penumbra predicts infarct growth. Stroke 1999; 30:1583-1590.
6. Kimura K, Sakamoto Y, Iguchi Y, Shibazaki K. Serial changes in ischemic lesion volume and neurological recovery after t-PA therapy. J Neurol Sci 2011; 304:35-39.
7. Schwamm LH, Koroshetz WJ, Sorensen AG etal. Time course of lesion development in patients with acute stroke: serial diffusion- and hemodynamic-weighted magnetic resonance imaging. Stroke 1998; 29:2268-2276.
8. Barrett KM, Ding YH, Wagner DP, Kallmes DF, Johnston KC. Change in diffusion-weighted imaging infarct volume predicts neurologic outcome at 90 days: results of the Acute Stroke Accurate Prediction (ASAP) trial serial imaging substudy. Stroke 2009; 40:2422-2427.
9. Merino JG, Latour LL, Todd JW etal. Lesion volume change after treatment with tissue plasminogen activator can discriminate clinical responders from nonresponders. Stroke 2007; 38:2919-2923.
10. Pantano P, Caramia F, Bozzao L, Dieler C, von Kummer R. Delayed increase in infarct volume after cerebral ischemia: correlations with thrombolytic treatment and clinical outcome. Stroke 1999; 30:502-507.
11. Humpich M, Singer OC, du Mesnil de Rochemont R, Foerch C, Lanfermann H, Neumann-Haefelin T. Effect of early and delayed recanalization on infarct pattern in proximal middle cerebral artery occlusion. Cerebrovasc Dis 2006; 22:51-56.
12. Neumann-Haefelin T, du Mesnil de Rochemont R, Fiebach JB etal. Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study. Stroke 2004; 35:109-114.
13. Pialat JB, Wiart M, Nighoghossian N etal. Evolution of lesion volume in acute stroke treated by intravenous t-PA. J Magn Reson Imaging 2005; 22:23-28.
14. Uno M, Harada M, Yoneda K, Matsubara S, Satoh K, Nagahiro S. Can diffusion- and perfusion-weighted magnetic resonance imaging evaluate the efficacy of acute thrombolysis in patients with internal carotid artery or middle cerebral artery occlusion? Neurosurgery 2002; 50:28-34. discussion 34-25.
15. Kidwell CS, Saver JL, Mattiello J etal. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 2000; 47:462-469.
16. Sakamoto Y, Kimura K, Iguchi Y, Shibazaki K, Aoki J. Dramatic changes of a DWI lesion in a patient with acute ischemic stroke treated with IV t-PA. J Neuroimaging. 2011 Aug 17. doi: 10.1111/j.1552-6569.2011.00635.x. [Epub ahead of print]
17. Yamaguchi T, Mori E, Minematsu K etal. Alteplase at 0·6mg/kg for acute ischemic stroke within 3h of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke 2006; 37:1810-1815.
18. Adams HP Jr, Bendixen BH, Kappelle LJ etal. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24:35-41.
19. Barber PA, Darby DG, Desmond PM etal. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 1998; 51:418-426.
20. Davis SM, Donnan GA, Parsons MW etal. Effects of alteplase beyond 3h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008; 7:299-309.
21. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 1985; 312:932-936.
22. Chemmanam T, Campbell BC, Christensen S etal. Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch. Neurology 2010; 75:1040-1047.
23. Campbell BC, Purushotham A, Christensen S etal. The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J Cereb Blood Flow Metab 2012; 32:50-56.
24. Arenillas JF, Rovira A, Molina CA, Grive E, Montaner J, Alvarez-Sabin J. Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke. Stroke 2002; 33:2197-2203.
25. Olivot JM, Mlynash M, Thijs VN etal. Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE). Stroke 2008; 39:2257-2263.
26. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology 2000; 217:331-345.
27. Bardutzky J, Shen Q, Henninger N, Schwab S, Duong TQ, Fisher M. Characterizing tissue fate after transient cerebral ischemia of varying duration using quantitative diffusion and perfusion imaging. Stroke 2007; 38:1336-1344.
28. Baird TA, Parsons MW, Phanh T etal. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003; 34:2208-2214.
29. Parsons MW, Barber PA, Desmond PM etal. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002; 52:20-28.
30. Li F, Silva MD, Liu KF etal. Secondary decline in apparent diffusion coefficient and neurological outcomes after a short period of focal brain ischemia in rats. Ann Neurol 2000; 48:236-244.
31. Burdette JH, Elster AD, Ricci PE. Acute cerebral infarction: quantification of spin-density and T2 shine-through phenomena on diffusion-weighted MR images. Radiology 1999; 212:333-339.
32. Tourdias T, Renou P, Sibon I etal. Final cerebral infarct volume is predictable by MR imaging at 1 week. AJNR Am J Neuroradiol 2011; 32:352-358.